Light Therapy for Dry Eyes: How the Treatment Works

Light therapy for dry eyes works primarily by targeting the oil-producing glands in your eyelids, using either intense pulsed light (IPL) or low-level light therapy (LLLT) to restore the protective lipid layer of your tear film. The dominant form of dry eye disease stems from dysfunction in these tiny glands, and light-based treatments tackle the problem through a combination of heat, inflammation reduction, and cellular stimulation that conventional eye drops cannot replicate. The science behind it is more layered than a simple “heat melts the blockage” story, and the clinical evidence has matured enough that these therapies are now part of mainstream ophthalmology practice.

Why Oil Glands Matter More Than Tear Volume

Most people think of dry eyes as a problem of not making enough tears. That is sometimes true, but the more common culprit is evaporative dry eye, where tears evaporate too quickly because the oily outer layer of the tear film is deficient. That oil comes from meibomian glands, dozens of tiny glands embedded in your upper and lower eyelids. When they work properly, every blink spreads a thin film of oil (meibum) over your tears, slowing evaporation. When they do not, your tears vanish faster than your body can replace them.

Meibomian gland dysfunction, or MGD, is the leading cause of dry eye disease and one of the most common problems eye doctors see. The glands become blocked, the oil thickens or changes composition, and the consequences cascade: faster tear evaporation, irritation, inflammation, surface damage to the cornea, and blurred vision that fluctuates with each blink.¹ The inadequate quantity or quality of lipids produced by the meibomian glands is what drives the evaporative form of the disease.²

Traditional treatments like warm compresses, lid scrubs, and lubricating drops all try to manage the symptoms or coax the glands into working better. They help, but the effects tend to be modest and short-lived. Light therapy represents a fundamentally different approach: rather than working around the dysfunction, it aims to change the glands’ environment and function at a deeper level.

How Intense Pulsed Light Treats the Glands

IPL was originally developed for dermatology, specifically for treating rosacea and removing unwanted blood vessels near the skin surface. Eye doctors noticed that patients getting IPL for facial rosacea often reported that their dry eyes improved too. That observation, which dates back to the early 2000s, launched a line of research that has since produced its own body of evidence.

The device emits broad-spectrum light pulses, typically in the visible and near-infrared range, directed at the skin around the eyes (not into the eyes themselves). The light interacts with tissue in several ways, and researchers believe the therapeutic effect comes from multiple mechanisms working together rather than any single one.

The most intuitive mechanism is heat. In MGD, the meibum inside the glands thickens and solidifies at a higher temperature than normal. Healthy meibum melts around 28°C, but in people with MGD, the melting point rises above 32°C. Home warming devices can raise eyelid skin temperature to about 34°C, but that warmth dissipates within minutes and is not enough to keep the abnormal meibum liquid. IPL, by contrast, can raise the temperature of small blood vessels in the targeted skin area to between 45°C and 70°C, generating enough sustained heat to reach the meibomian glands and liquefy thickened secretions.³

That said, the thermal explanation is not universally accepted. Some researchers argue that IPL pulses are too brief to create sustained temperature changes in deeper tissue, and that any surface warming is fleeting.⁴ The debate matters because it suggests the thermal effect, while probably real, is not the whole story.

Beyond Heat: Inflammation and Blood Vessels

A second mechanism involves the abnormal blood vessels that proliferate around inflamed eyelid margins. IPL is already well established as a treatment for skin conditions involving dilated or overgrown blood vessels, including rosacea, and there is a clear association between rosacea and dry eye disease.⁵ When IPL light is absorbed by hemoglobin in these vessels, it generates localized heat that causes the vessel walls to collapse and seal. Closing off these abnormal vessels reduces the supply of inflammatory mediators reaching the eyelid margin and the meibomian glands.

The anti-inflammatory effect shows up in measurable ways. One study comparing IPL to a standard regimen of antibiotic and steroid drops plus warm compresses found that IPL produced lower levels of inflammatory markers in tears, including interleukin-17A and interleukin-1β, within a week of treatment.⁶ Reducing chronic inflammation around the glands may be what allows them to recover function over time, rather than just providing temporary symptom relief.

Killing Mites and Bacteria on the Eyelids

A less obvious benefit of IPL involves the microorganisms living on your eyelid margins. Demodex mites, tiny parasites that burrow into eyelash follicles, are a recognized contributor to eyelid inflammation and MGD. IPL treatment appears to reduce Demodex populations substantially. In one study of patients with both MGD and Demodex infestation, the average mite count dropped from about seven per patient at baseline to roughly one after three treatment sessions, with an eradication rate exceeding 80% by the third month.⁷

The effect on mite density does seem to vary between patients, and the mechanism is not entirely clear: it may be direct thermal killing, disruption of the mites’ habitat, or both.⁸ Regardless, for people whose dry eye is partly driven by Demodex, addressing the infestation through IPL may explain why the treatment works when drops and lid hygiene have not.

Low-Level Light Therapy and Cellular Energy

LLLT, sometimes called photobiomodulation, is the other major light-based approach. It operates on a completely different principle than IPL. Where IPL works partly through selective heating of blood vessels and tissue, LLLT uses much lower energy levels, typically in red or near-infrared wavelengths, to stimulate cellular activity without generating meaningful heat.

The target is an enzyme called cytochrome c oxidase, which sits inside your cells’ mitochondria and plays a central role in energy production. This enzyme has metal centers that absorb light across roughly 600 to 1,000 nanometers. When photons hit those centers, they knock off a molecule of nitric oxide that has been inhibiting the enzyme’s function. With the brake released, the mitochondria ramp up ATP production, giving cells more energy for repair and normal function.⁹ The freed nitric oxide also has downstream signaling effects that may promote blood flow and modulate inflammation.¹⁰

Applied to the eyelids, the idea is that LLLT boosts the metabolic health of meibomian gland cells, helping them produce better-quality oil and recover from the chronic stress of dysfunction. The energy levels are low enough that patients typically feel only gentle warmth or nothing at all during treatment.

Combining IPL and LLLT

In clinical practice, many newer treatment protocols pair IPL with LLLT in the same session, applying IPL first and following it immediately with a LLLT mask worn over the eyes. The rationale is straightforward: IPL addresses the vascular, thermal, and antimicrobial components, while LLLT adds a cellular-repair stimulus. A systematic review of studies using this combination found that patients showed meaningful improvements across multiple measures, including symptom scores, tear film stability, lipid layer thickness, and meibomian gland function.¹¹

A randomized controlled trial comparing combined IPL and LLLT against a control group confirmed that the combination was effective for treating MGD with evaporative dry eye and that repeated sessions had a cumulative benefit.¹² A retrospective study following patients for a full year after four combined sessions found that symptoms and signs improved dramatically after completing treatment, and while some of the benefit faded over the following months, the results still remained significantly better than baseline a year later.¹³

What the Clinical Numbers Look Like

The most commonly tracked metric in dry eye research is tear break-up time (TBUT), which measures how many seconds your tear film stays intact between blinks. A longer TBUT means a more stable tear film and less evaporation. In a multicenter randomized trial, IPL combined with meibomian gland expression increased TBUT by an average of 2.3 seconds compared to 0.5 seconds in a control group receiving expression alone. Symptom scores dropped by about 38% in the IPL group versus 22% in controls, and the amount of oil the glands could express nearly tripled.¹⁴

Longer-term data tells a similar story. A one-year follow-up study found that tear film stability improved by an average of about four seconds, and detailed tear film analysis showed substantial improvements in stability scores.¹⁵ Another study found that at 12 weeks after treatment, the IPL group had a mean tear break-up time roughly 50% higher than the control group.¹⁶

These are not transformative numbers on their own, but for a condition where even a couple of extra seconds of tear stability can mean the difference between constant discomfort and a manageable day, they are clinically meaningful. The improvements also tend to be cumulative: each successive session builds on the last.

What a Treatment Session Looks Like

A standard course of IPL for dry eyes involves three to four sessions, typically spaced two to four weeks apart.¹⁷ Before the procedure, a coupling gel is applied to the skin below the eyes and across the cheeks. Protective eye shields, either external goggles or opaque contact-lens-style shields placed directly on the eye, are essential because IPL light can damage intraocular structures. The clinician then delivers a series of light pulses along the lower eyelid and cheekbone, occasionally the upper lid area as well. The pulses feel like a warm snap against the skin. After IPL, many clinics add a 15-minute LLLT session using an LED mask.

Following the light treatment, the clinician usually performs meibomian gland expression: gentle pressure on the eyelids to squeeze out the now-softened oil. This manual expression is considered an important companion step, though some newer protocols rely on the light therapy alone. The whole visit, including prep and expression, typically takes 20 to 30 minutes. If necessary, maintenance sessions can be scheduled every 4 to 12 months.

Safety and Who Can Get Treated

IPL is generally well tolerated. The most common side effects are temporary redness and mild warmth on the treated skin, similar to a mild sunburn that fades within hours. The more serious risk involves skin pigmentation changes, which is why the patient’s skin type matters. The Fitzpatrick scale, which classifies skin from very fair (type I) to very dark (type VI), guides energy settings. Fair skin reflects more of the light and requires higher energy, while darker skin absorbs more energy due to higher melanin content, raising the risk of burns or pigment changes.

For years, IPL was limited to patients with Fitzpatrick skin types I through IV, effectively excluding many people with darker skin. That restriction has loosened as newer devices have been engineered for broader use. Some current platforms are approved for type V with reduced flash intensity, and at least two device manufacturers now allow treatment across all skin types, including type VI.¹⁷ That said, darker skin types still require more cautious energy settings and a practitioner experienced with those protocols.

Eye protection during treatment is non-negotiable. The light wavelengths used in IPL can cause retinal damage if they reach the back of the eye, so proper shielding, whether external goggles or corneal shields, must be in place for every pulse. People with active eye infections, certain eyelid conditions, or a history of photosensitive seizures may not be good candidates. Pregnancy is also typically listed as a contraindication, largely out of caution.

How IPL Compares to Thermal Pulsation Devices

LipiFlow is the best-known alternative in-office treatment for MGD. It works differently from IPL: a dome-shaped device sits on the eye, applying controlled heat to the inner eyelid surface while simultaneously delivering pulsing pressure from outside to physically express the glands.¹⁸ The mechanism is purely thermal and mechanical, with no light-based anti-inflammatory or antimicrobial component.

No head-to-head randomized trial has directly compared IPL to LipiFlow. A recent network meta-analysis pooling data from 12 trials and nearly 1,000 patients attempted an indirect comparison. Both treatments improved tear break-up time and symptoms, but IPL showed a larger average improvement in TBUT (about two additional seconds versus under one second for LipiFlow) and a greater reduction in one symptom questionnaire. LipiFlow performed better on a different symptom scale. The authors stressed that these are indirect comparisons with different control groups across studies, so the relative rankings should be taken cautiously.¹⁹

In practice, the choice between IPL and LipiFlow often comes down to what your eye doctor has available, your skin type, and whether you have coexisting conditions like rosacea or Demodex blepharitis that would benefit from IPL’s additional mechanisms. Some patients receive both over time.

How Long Results Last and the Maintenance Question

One of the advantages of light therapy over daily drops or warm compresses is that the benefits persist for months after a treatment course. A meta-analysis of IPL studies noted that the effects are sustained over several months, which is particularly helpful for patients who struggle with the daily compliance that conventional treatments demand.²⁰ The one-year follow-up data on combined IPL/LLLT showed that while peak improvement occurred right after completing the four-session course, a meaningful benefit over baseline was still present at the 12-month mark.¹³

The gradual fade-back is expected. MGD is a chronic condition, and light therapy does not cure it permanently. Most clinicians recommend maintenance sessions once or twice a year to sustain the gains. Some patients can go longer between sessions, and some need them more frequently, depending on the severity of their gland disease and how much structural damage the glands have already sustained. Glands that have atrophied (essentially shriveled and disappeared, visible on infrared imaging) cannot be brought back by any current therapy, so treating MGD before it reaches that stage gives light therapy the best chance of working.

Cost, Insurance, and Practical Access

Light therapy for dry eyes sits in an awkward spot financially. A single IPL session typically costs several hundred dollars in the United States, and a full initial course of three to four sessions can run over a thousand dollars. Insurance coverage is inconsistent: some plans cover it, especially when documented MGD has not responded to first-line treatments, but many consider it elective or experimental and will not pay.

Researchers have acknowledged that while adding IPL to standard care appears to improve outcomes, cost-effectiveness studies are still lacking. Further research is needed to assess the cost-utility of IPL in clinical practice, particularly since many patients also continue using other therapies alongside it.²⁰ In the meantime, patients and doctors are weighing the upfront cost against the ongoing expense of prescription drops, warm-compress devices, and the productivity lost to chronic discomfort.

When Light Therapy Might Help With Pain Beyond Dryness

Some patients with dry eye disease experience pain that seems out of proportion to the visible damage on their eye surface. This disconnect between symptoms and signs is often attributed to neuropathic pain, where the corneal nerves themselves become sensitized and fire pain signals even when the surface looks relatively healthy. It is one of the more frustrating presentations for both patients and doctors because conventional dry eye treatments may not touch the pain.

Early evidence suggests IPL may help in these cases too. A study of patients with MGD and presumed neuropathic pain found significant improvement in both ocular surface parameters and pain-related symptom scores two and four months after completing IPL treatment. Tear film stability, corneal surface damage, and gland obstruction all improved alongside the pain reduction. Whether the pain relief comes from resolving underlying inflammation that was driving the nerve sensitization, from a direct effect on nerve function, or both, remains an open question, but the results suggest that light therapy’s benefits may extend beyond what standard gland function metrics capture.

Tear Lipids and the Limits of What We Can Measure

One puzzle in the research is that IPL clearly improves clinical signs and symptoms of dry eye, but the corresponding changes in tear composition are not always as dramatic as you might expect. A case-control study looking at tear lipid profiles in women with dry eye found that while IPL significantly improved clinical metrics like tear break-up time and surface staining, the changes in the actual lipid molecules detected in tears were not statistically significant.²¹

This does not mean the treatment is not working. It may mean that current lipidomic analysis is not sensitive enough to capture the relevant changes, that the improvements are more about meibum flow and physical gland function than about wholesale shifts in lipid chemistry, or that the anti-inflammatory effects matter more than the lipid effects for symptom relief. For the patient, the practical takeaway is that feeling better and having a more stable tear film are the outcomes that matter, even if researchers are still working out exactly which molecular changes are driving those improvements.